Forest Cipramil (citalopram) low level of drug-drug interactions is benefit for elderly, annual report says.

Executive Summary

FOREST TOUTS CIPRAMIL (CITALOPRAM) LOW LEVEL OF DRUG-DRUG INTERACTIONS in its recently-released annual report for fiscal 1997 (ended March 31). Forest filed an NDA for the selective serotonin reuptake inhibitor, licensed from the Danish firm H. Lundbeck, on May 12 under the brand name Cipramil ("The Pink Sheet" May 19, In Brief). "Recent data indicates that among the SSRIs, citalopram may be least likely to cause potential drug-drug interactions," Forest maintained in the annual report. Wyeth's promotions discussing Effexor's drug-drug interaction potential recently were cited by FDA's ad division.